FDA authorizes second COVID-19 booster for older adults, certain others

Mar 29, 2022 - 03:40 PM
AHA COVID Vaccine Resources

The Food and Drug Administration today authorized, and CDC recommended, a second Pfizer or Moderna COVID-19 vaccine booster dose for adults aged 50 and older at least four months after an initial booster dose. The agencies also authorized and recommended a second Moderna booster dose for certain immunocompromised adults, and a second Pfizer booster dose for certain immunocompromised individuals aged 12 or older. Based on an analysis of emerging data, a second booster dose “could help increase protection levels for these higher-risk individuals,” said Mark Peters, M.D., director of FDA’s Center for Biologics Evaluation and Research. 

In other vaccination news, President Biden today announced plans to expand the Federal Retail Pharmacy program to 20,000 more pharmacies by April 19 so that 90% of Americans can access a COVID-19 vaccine site within 5 miles. He also announced almost $100 million in Department of Health and Human Services funding to help older adults and people with disabilities get to a vaccination site; and plans to stand up 12 new federally run mass vaccination sites. 

Related News Articles

Headline
View the AHA's latest United Against the Flu toolkit celebrating fall
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
CDC reminds hospital and health system workers to protect themselves, patients during respiratory virus season
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Chair File: The Best Defense Against Flu and COVID-19
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
Survey: Less than 20% of U.S. adults concerned for themselves or family receiving infection ahead of respiratory virus season
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…